Citi Says Buy the Dip in Bristol-Myers (BMY) Shares
Tweet Send to a FriendGet Alerts BMY Hot Sheet
Price: $46.05 -1.71%
Rating Summary:
8 Buy, 7 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 22
Rating Summary:
8 Buy, 7 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 22
Trade BMY Now!
An analyst at Citi is recommending investors buy shares of Bristol-Myers Squibb (NYSE: BMY) following Monday's 3.5 percent decline on the heels of an FDA delay for ELIQUIS. The analyst said the delay is "not substantial."
The stock has not yet traded in Tuesday's pre-open session. Shares closed at $34.13 on the NYSE on Monday.
Visit our Analyst Ratings page to track all the market-moving analyst action on shares of Bristol-Myers.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The stock has not yet traded in Tuesday's pre-open session. Shares closed at $34.13 on the NYSE on Monday.
Visit our Analyst Ratings page to track all the market-moving analyst action on shares of Bristol-Myers.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Bristol-Myers Squibb (BMY) Adds Harmon's Paliwal to Board
- Gabelli Downgrades Nexstar Broadcasting Group (NXST) to Hold
- Goldman Sachs Upgrades Tanger Factory Outlet Centers (SKT) to Neutral
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Citi
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
